Advocacy plays a vital role in highlighting the needs, safeguarding the rights and participation of people with allergy and respiratory disease. These diseases threaten society with increasing costs and can reduce quality of life and number of healthy life years for children and adults across Europe.

A common concern among patients are that these diseases are not considered as important as other chronic diseases within the public opinion and among European policy makers. This leads to ignorance about the causes and consequences of allergy, asthma and COPD, which negatively affects patients and increases the problem over time.

As a federation advocating for patients with allergy, asthma and COPD, we aim to raise the profile of allergy and airways diseases, to position them as chronic and sometimes severe diseases among the public.

Voicing the patient perspective

Advocacy allows for constructive participation and integration of patients perspective in EU policy formulation. EFA acts as a liaison between people with allergy, asthma and COPD and the EU policymakers, enabling the patient perspective across the decision and legislative process.

We voice together with our members, patient experiences at European level to advance and shape policy. We collect and share best national practices on care, prevention and patient participation at European level to raise the standards of care, environment, patient participation and research.

We actively follow changes to EU legislation that may directly impact the lives of allergy, asthma and COPD patients. We promote awareness of such impactful changes towards policy makers. We connect the decisions made by the EU with real people through our network of patients and we bring back to the political representatives the results these decisions have in everyday lives.

The relationship between European policy and European citizens becomes even more important, given the complex procedures and emphasis on implementation of EU policy at national level. We keep our network of patient organisations alive and updated on developments at EU level and best examples in fellow countries.

EFA advocacy themes:



Access to healthcare


Medicines and clinical trials 



Food labelling


Tobacco and smoking



Air quality





 For more information on our advocacy intiatives, please contact EFA Senior EU Policy Adviser Roberta Savli (This email address is being protected from spambots. You need JavaScript enabled to view it.).

Dear Visitor,
Our website is currently under construction and some sections may be incomplete or missing. If you need any information that you cannot currently find on the website, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..
Thanks for your understanding, the EFA Team.